A Joel
Overview
Explore the profile of A Joel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Joel A, Abarna R, Chacko R, Singh A, Georgy J, John A, et al.
Klin Onkol
. 2024 Aug;
37(1):40-49.
PMID: 39183550
Background: To determine if circulating tumor DNA (ct-DNA) dynamics of epidermal growth factor receptor (EGFR) mutation in plasma can identify a subset of patients with EGFR-mutant (EGFR- m) non-small cell...
2.
Georgy J, Singh A, John A, Joel A, Andrews A, Thumaty D, et al.
Klin Onkol
. 2021 Mar;
34(1):49-55.
PMID: 33657819
Background: Response to neoadjuvant chemotherapy is associated with improved outcomes for patients with triple negative breast cancer (TNBC). Patients with residual disease are at increased risk of relapse and death...
3.
Malcomson F, Breininger S, ElGendy K, Joel A, Ranathunga R, Hill T, et al.
Nutr Health
. 2019 Aug;
25(3):231-238.
PMID: 31370734
Background: Colorectal cancer (CRC) is the third most common cancer worldwide. Age is the strongest non-modifiable risk factor but it is estimated that over half of CRC cases are linked...
4.
Joel A, Samuel A, Bhatt A, Chandramohan A, Chacko R
Indian J Cancer
. 2016 Feb;
52(2):230-1.
PMID: 26853417
No abstract available.
5.
Bhatt A, Pai R, Rebekah G, Nehru G, Dhananjayan S, Samuel A, et al.
Indian J Cancer
. 2013 Aug;
50(2):94-101.
PMID: 23979198
Introduction: We performed retrospective analysis of 106 patients with lung cancer for which formalin-fixed paraffin-embedded tissues was available. Their epidermal growth factor receptor (EGFR) mutation status and treatment outcomes are...
6.
Avivi A, Ashur-Fabian O, Joel A, Trakhtenbrot L, Adamsky K, Goldstein I, et al.
Oncogene
. 2006 Oct;
26(17):2507-12.
PMID: 17043642
A tumor suppressor gene, p53, controls cellular responses to a variety of stress conditions, including DNA damage and hypoxia, leading to growth arrest and/or apoptosis. Recently, we demonstrated that in...
7.
Andrieu S, Bocquet H, Joel A, Gillette-Guyonnet S, Nourhashemi F, Salva A, et al.
J Nutr Health Aging
. 2005 Mar;
9(2):121-6.
PMID: 15791357
Background: Informal caregivers play a major role in all types of assistance for elderly persons with Alzheimer's disease but few longitudinal studies reports change in this role over time. Objective:...
8.
Hough R, Avivi A, Davis J, Joel A, Nevo E, Piatigorsky J
Proc Natl Acad Sci U S A
. 2002 Jun;
99(12):8145-50.
PMID: 12060761
Blind mole rats have degenerated subcutaneous eyes that are visually nonfunctional. In this investigation, we have compared the tissue specificity of the small heat shock protein (shsp)/alphaB-crystallin promoter of the...
9.
Zoossmann-Diskin A, Joel A, Liron M, Kerem B, Shohat M, Peleg L
Ann Hum Biol
. 2002 Mar;
29(2):142-75.
PMID: 11874621
Background: A considerable body of data has been accumulated since the 1960s on protein electrophoretic markers in the Jewish populations of Israel. However, in some Jewish communities and for some...
10.
Avivi A, Albrecht U, Oster H, Joel A, Beiles A, Nevo E
Proc Natl Acad Sci U S A
. 2001 Nov;
98(24):13751-6.
PMID: 11707566
Blind subterranean mole rats retain a degenerated, subcutaneous, visually blind but functionally circadian eye involved in photoperiodic perception. Here we describe the cloning, sequence, and expression of the circadian Clock...